Adapting the Shed-MEDS Deprescribing Intervention to Dementia Care in Assisted Living
Completed · Not applicable
Conditions studied: Polypharmacy, Dementia, Quality of Life
In brief
This single-arm pilot study will evaluate the effects of an intervention to reduce exposure to unnecessary or potentially harmful medications among residents with dementia living in an assisted living facility. The goal of the intervention is to safely deprescribe medications (defined by dose reductions and stopped medications), based on a combination of clinical criteria and resident/surrogate preferences. The investigators will evaluate the effects of the intervention on the total number of medications deprescribed from enrollment at 30, 60, and 90 days along with resident/surrogate reports of quality of life at enrollment and 90 days.
Key facts
- Study ID
- NCT05956665
- Run by
- Vanderbilt University
- People needed
- 18
- Starts
- 2024-01-23
- Expected to finish
- 2025-08-15
- Last updated by the study team
- 2025-10-15
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Resident of assisted living facility
- Speaks English (due to interview-based assessments)
- Diagnosis of dementia
- Taking a total of 5 medications or at least one potentially inappropriate medication (defined by the Beers criteria, STOPP criteria, and the Rationalization of home medication by an Adjusted STOPP in older Patients [RASP])
- Able self-consent or has a proxy (surrogate)
You may not qualify if…
- None
Where it is running
- Abe's Garden Community — Nashville, Tennessee, United States
- NHC At The Trace — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.